Piper Jaffray initiated coverage on Nantkwest Inc NK with a Overweight rating. The target price for Nantkwest is set to $38. Nantkwest shares closed at $23.80 on Friday.
Analysts at Morgan Stanley initiated coverage on Interactive Intelligence Group Inc ININ with a Equal-weight rating. The target price for Interactive Intelligence is set to $45. Interactive Intelligence shares closed at $37.00 on Friday.
Analysts at Credit Suisse initiated coverage on Johnson Controls Inc JCI with a Neutral rating. The target price for Johnson Controls is set to $49. Johnson Controls shares closed at $42.11 on Friday.
H.C. Wainwright initiated coverage on Sucampo Pharmaceuticals, Inc. SCMP with a Buy rating. The target price for Sucampo Pharmaceuticals is set to $31. Sucampo Pharmaceuticals shares closed at $25.15 on Friday.
Analysts at Citigroup initiated coverage on Nantkwest Inc NKwith a Buy rating. The target price for Nantkwest is set to $45. Nantkwest shares closed at $23.80 on Friday.
Analysts at Stifel Nicolaus initiated coverage on vTv Therapeutics Inc VTVT with a Buy rating. The target price for vTv Therapeutics is set to $17. vTv Therapeutics shares closed at $8.85 on Friday.
Analysts at Piper Jaffray initiated coverage on Pinnacle Financial Partners PNFP with a Neutral rating. The target price for Pinnacle Financial Partners is set to $53. Pinnacle Financial Partners shares closed at $48.79 on Friday.
Analysts at Jefferies initiated coverage on Nantkwest Inc NK with a Buy rating. The target price for Nantkwest is set to $23. Nantkwest shares closed at $23.80 on Friday.
Analysts at Morgan Stanley initiated coverage on Zebra Technologies Corp. ZBRA with a Overweight rating. The target price for Zebra Technologies is set to $115. Zebra Technologies shares closed at $81.25 on Friday.
Analysts at Piper Jaffray initiated coverage on vTv Therapeutics Inc VTVT with a Overweight rating. The target price for vTv Therapeutics is set to $24. vTv Therapeutics shares closed at $8.85 on Friday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in